{
  "retracted": false,
  "timestamp": 1555286400000,
  "updates": [
    {
      "timestamp": 1559646812080,
      "identifier": {
        "doi": "10.1007/s10549-019-05218-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-019-05166-3"
  },
  "journal": "Breast Cancer Research and Treatment",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer"
}
